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Abstract The effect of 3P-azido-3P-deoxythymidine on nucleo-
side diphosphate kinase of isolated rat liver mitochondria has
been studied. This is done by monitoring the increase in the rate
of oxygen uptake by nucleoside diphosphate (TDP, UDP, CDP
or GDP) addition to mitochondria in state 4. It is shown that
3P-azido-3P-deoxythymidine inhibits the mitochondrial nucleoside
diphosphate kinase in a competitive manner, with a Ki value of
about 10 WM as measured for each tested nucleoside diphosphate.
It is also shown that high concentrations of GDP prevent
3P-azido-3P-deoxythymidine inhibition of the nucleoside diphos-
phate kinase.
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1. Introduction
A large body of evidence shows that mitochondria are se-
lective cell targets of 3P-azido-3P-deoxythymidine (AZT), with
many dramatic structural and functional changes described,
induced by both long-term and short-term AZT treatment
(for a review see [1]). Although it is commonly accepted
that mitochondria-AZT interaction is the principal cause of
AZT cytotoxicity, the elucidation of the processes leading to
the impairment of the energy metabolism, i.e. the ATP de¢-
ciency syndrome [2], remains far from being exhaustively
clari¢ed. Thus, the identi¢cation of the AZT mitochondrial
molecular targets is still a suitable goal to pursue. In this
regard, we have recently found that adenylate kinase [3] and
the ADP/ATP carrier [4] are strongly inhibited by AZT in rat
liver mitochondria (RLM) isolated in vitro.
This work deals with the e¡ect of AZT on the mitochon-
drial nucleoside diphosphate kinase (NDPK) (EC 2.7.4.6), the
enzyme which plays a crucial role in the regulation and the
channelling of intracellular energy phosphate metabolites [5],
being an important link between the cellular pool of ATP,
maintained by catabolic metabolism, and the NTP utilised
for various intracellular anabolic reactions.
In RLM, NDPK is mainly localised in the intermembrane
space [6], where it catalyses the reversible transfer of the ter-
minal phosphoryl group of ATP or an other NTP to NDP
acceptors. Thus, it seems worthwhile to ¢nd out whether AZT
interaction with the mitochondrial enzyme can occur. In order
to achieve this, experiments were made aimed at ascertaining
whether and how externally added AZT can a¡ect NDPK as
measured in coupled RLM in vitro by using separately TDP,
UDP, CDP and GDP as phosphate acceptor for newly syn-
thesised ATP via oxidative phosphorylation.
We show that AZT is a potent competitive inhibitor of the
mitochondrial NDPK in isolated RLM and that externally
added GDP can prevent AZT inhibition.
2. Materials and methods
All chemicals were from Sigma Chemical Co. (St. Louis, MO,
USA). Mitochondrial substrates were used as Tris salts at pH 7^7.3.
The RLM were isolated as described [4] from male Wistar rats,
(200^250 g) fed ad libitum and suspended in the standard medium
containing 0.25 M sucrose, 1 mM EDTA, 10 mM Tris-HCl pH 7.25.
Mitochondrial preparations showing a respiratory control index
(RCI) lower than three were discarded. Mitochondrial protein was
determined according to Waddel and Hill [7].
Oxygen uptake measurements were carried out at 25‡C by means of
a Gilson 5/6 oxygraph using a Clark electrode. RLM (2 mg protein)
were added to 2 ml of the respiration medium consisting of 210 mM
mannitol, 70 mM sucrose, 0.1 mM EGTA, 20 mM Tris-HCl, 5 mM
potassium phosphate (pH 7.4), 3 mM MgCl2 in the presence of 2 Wg
rotenone. 5 mM succinate was used as a respiratory substrate and
160 WM ADP was used to induce state 3 respiration.
The NDPK reaction was assayed by measuring the stimulated res-
piration rate (SRR) due to TDP, UDP, CDP or GDP addition (up to
150 WM) to RLM at the completion of state 3/state 4 transition [6].
The SRR was calculated as the di¡erence between the NDPrate and
the state 4 post ADPrate, where the NDPrate refers to the initial rate of
respiration obtained when each single NDP was added and state 4
post ADPrate represents the rate of respiration following the state 3 to
state 4 transition. Measurements made in triplicate with the same
mitochondrial preparation gave a S.D. lower than 3%.
3. Results
In order to investigate the e¡ect of AZT on NDP-depend-
ent SRR in coupled mitochondria, in a typical experiment
(Fig. 1A) RLM were added with succinate (5 mM) with the
oxygen uptake continuously measured. ADP addition
(160 WM) to RLM was found to stimulate the rate of oxygen
uptake (RCI higher than 4). At the completion of the state 3/
state 4 transition, mitochondria were added with TDP (a),
UDP (b), CDP (c) or GDP (d) (50 WM each) either in the
absence or in the presence of AZT (15 WM). All the tested
NDPs were found to stimulate the respiratory rate: thus the
SRRs were 23, 26, 10 and 24 ngat. O/min/mg protein for
TDP, UDP, CDP and GDP, respectively. Externally added
AZT (15 WM) was found to decrease the NDP-dependent
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SRR by 48, 42, 50 and 46% for TDP, UDP, CDP and GDP,
respectively. In agreement with [6], in a control experiment,
GDP (600 WM) proved to prevent SRR completely (data not
shown).
As previously proposed [6], the explanation for the ob-
served NDP-dependent SRR is that the externally added
NDP is phosphorylated in the intermembrane space to the
corresponding NTP by the e¥uxed ATP. The newly synthe-
sised ADP enters the matrix, via an ADP/ATP carrier, where
it is phosphorylated to ATP, via ATP synthase, with the con-
sequent stimulation of the respiration (Fig. 1B).
Since SRR inhibition due to externally added AZT could be
a result of the impairment of the reaction catalysed by
NDPK, the ADP/ATP carrier or ATP synthase, the control
strength criterion [8] was applied to identify the rate-limiting
step of the NDP-dependent SRR under our experimental con-
ditions. Thus, two inhibitors were used: carboxyatractyloside
(CAT), the inhibitor of the ADP/ATP carrier and oligomycin,
the inhibitor of the ATP synthase. Unfortunately, no inhibitor
of the mitochondrial NDPK [9] can be used at present. In a
typical experiment (Fig. 2), TDP (150 or 300 WM) was used as
a NDPK substrate in the presence of increasing concentra-
tions of CAT, oligomycin or AZT. At 150 WM TDP, no
SRR inhibition was found when either CAT (0^0.015 WM)
(Fig. 2A, 8), or oligomycin (0^0.05 Wg/mg protein) (Fig.
2B, R) was added to RLM, showing that neither the ADP/
ATP translocator, nor the ATP synthase can limit the meas-
ured SRR, which re£ects the reaction catalysed by NDPK.
Under these conditions, SRR was inhibited by AZT (Fig.
2C, b). Obviously, the inhibition observed at increasing
CAT or oligomycin concentration is explained by the rate
of the ADP/ATP antiport or ATP synthesis, respectively, be-
coming the rate-limiting step of the measured process. On the
other hand, SRR induced by 300 WM TDP was inhibited by
CAT (Fig. 2A, W), but was insensitive to both oligomycin (0^
0.05 Wg/mg protein) (Fig. 2B, O) and AZT (Fig. 2C, a),
showing that the activity of the ADP/ATP carrier limits the
rate of the TDP-dependent SRR. Similar results were ob-
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Fig. 1. A: The e¡ect of AZT on the NDP-dependent SRR in isolated coupled RLM. RLM (2 mg of protein) were incubated at 25‡C in 2 ml
of the respiration medium in the presence of 2 Wg of rotenone. At the arrows, the following additions at the indicated concentrations were
made: succinate (SUCC) (5 mM), ADP (160 WM) and TDP (a), UDP (b), CDP (c) or GDP (d) (50 WM each). When present, AZT (15 WM)
was added to the mitochondrial suspension immediately before the NDP addition. Numbers along the traces indicate the rate of oxygen uptake
expressed as ngat. O/min/mg protein. B: Mechanism of stimulation of respiration rate induced by NDP addition to RLM. The scheme reports
the three di¡erent steps involved in the NDP-dependent SRR.
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tained using UDP and CDP (either 150 WM or 300 WM) and
GDP as NDPK substrates, as 300 WM GDP per se inhibited
the SRR [6], this substrate was used up to 150 WM (data not
shown). These results clearly show that AZT decreases the
NDP-dependent SRR by inhibiting the NDPK reaction,
which can be assayed by using NDP concentrations up to
150 WM. Thus, the dependence of NDP-induced SRR on sub-
strate concentrations was studied by using NDP concentra-
tions up to 150 WM (data not shown). Hyperbolic kinetics
were found: mean Km values of 51 þ 6, 57 þ 6, 103 þ 11 and
36 þ 4 WM for TDP, UDP, CDP and GDP, respectively, were
obtained, as calculated in three experiments carried out with
di¡erent mitochondrial preparations. These values are in
fairly good agreement with literature values [6].
The kinetic analysis of AZT inhibition of the mitochondrial
NDPK was carried out according to Dixon [10] by measuring
the dependence of SRR caused by single addition of TDP,
UDP, CDP, or GDP on AZT concentration (0^15 WM)
(Fig. 3). AZT was found to inhibit NDPK reaction in a com-
petitive manner, with Ki values of 9.5 (Fig. 3A), 10.0 (Fig.
3B), 9.4 (Fig. 3C) and 9.1 WM (Fig. 3D), in this experiment. A
statistical analysis, carried out by comparing results from
three di¡erent experiments, showed that the Ki values are
not statistically di¡erent (Ps 0.2).
In order to distinguish between pure and partial competitive
inhibition, the same data were plotted as the reciprocal of the
fractional inhibition (i) versus the reciprocal of the AZT con-
centration (see insets in Fig. 3). Pure competitive inhibition
was found to occur up to 100 WM NDP, as judged by the
ordinate intercept which is equal to 1, while, a partial com-
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Fig. 2. A Dixon plot of the inhibition by CAT, oligomycin and
AZT of the TDP-dependent SRR. RLM (2 mg protein) were incu-
bated under conditions described in the legend to Fig. 1. Either 150
WM or 300 WM TDP were added to RLM in the absence or in the
presence of increasing concentrations of CAT (A), oligomycin (B)
or AZT (C). TDP-dependent SRR values, measured as described in
Section 2 are expressed as ngat. O/min/mg protein.
Table 1
The e¡ect of GDP on the AZT inhibition of NDPK reaction
Substrate Addition SRR
(ng at.
O/minUmg
protein)
%
Imeasured
%
Itheoretical
TDP (50 WM) None 28 ^ ^
TDP (50 WM) AZT 16 43 43
TDP (100 WM) None 37 ^ ^
TDP (100 WM) AZT 27 27 25
TDP (50 WM) GDP 41 ^ ^
TDP (50 WM) GDP+AZT 37 10 28
UDP (50 WM) None 26 ^ ^
UDP (50 WM) AZT 14 46 46
UDP (100 WM) None 35 - ^
UDP (100 WM) AZT 27 23 23
UDP (50 WM) GDP 40 ^ ^
UDP (50 WM) GDP+AZT 33 18 26
CDP (50 WM) None 18 ^ ^
CDP (50 WM) AZT 9 50 50
CDP (100 WM) None 28 ^ ^
CDP (100 WM) AZT 17 39 40
CDP (50 WM) GDP 34 ^ ^
CDP (50 WM) GDP+AZT 28 18 24
GDP (50 WM) None 29 ^ ^
GDP (50 WM) AZT 18 38 38
GDP (100 WM) None 36 ^ ^
GDP (100 WM) AZT 26 28 28
TDP, UDP, CDP or GDP at the indicated concentrations were added
to RLM (2 mg of protein) either in the absence or in the presence of
GDP (50 WM). When indicated, AZT (15 WM) was also present. The
SRR values, calculated for each single NDP (either in the absence or
in the presence of GDP) in the absence of AZT, were taken as 100% of
control. Itheoretical (expressed in percentage) is calculated according to
the equation: % Itheoretical = (13Vi/Vo)U100, where: Vi = Vmax [NDP]/
(KmNDP (1+[AZT]/Ki)+[NDP]) and Vo = Vmax [NDP]/(KmNDP+[NDP]).
The Km values used in the reported equations were 51, 57, 103 and
36 WM for TDP, UDP, CDP and GDP, respectively and the Ki value
used was 10 WM. When GDP was present, the Km used to calculate
Itheoretical was taken equal to 36 WM. For further details see the text.
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petitive inhibition was found at the higher NDP concentration
used, as demonstrated by the ordinate intercept value which is
greater than 1 [11].
In order to identify a possible candidate to prevent AZT
inhibition of NDPK, SRRs were measured by using either 50
or 100 WM of each single NDP or 50 WM NDP plus 50 WM
GDP. In each case, NDP was added in the absence and in the
presence of 15 WM AZT (Table 1). We calculated the theoret-
ical inhibition due to AZT, assuming competitive inhibition,
with the above reported Km and AZT Ki values. When NDP
plus GDP were added together as substrates, the lowest Km
value (36 WM) was used, thus accounting for the least inhib-
ition expected in the case of competitive inhibition. The com-
parison made between the experimental and the theoretical
inhibition shows that GDP can somehow prevent AZT inhib-
ition.
In order to further con¢rm the capability of GDP to pre-
vent AZT inhibition and in the light of the reported capability
of GDP to act both as a substrate (up to 150 WM) and as an
inhibitor (above 150 WM) of NDPK [6], AZT (15 WM) was
added to RLM and SRR was measured as a function of the
GDP concentration (Fig. 4). In the 50^150 WM GDP concen-
tration range, competitive inhibition of SRR by AZT was
found (see inset in Fig. 4), as in Fig. 3D. On the other
hand, in the 150^250 WM GDP concentration range, no in-
hibition by AZT was observed, thus con¢rming the capability
of GDP to prevent AZT inhibition.
4. Discussion
This paper shows that AZT can inhibit the rate of NDPK
reaction in isolated coupled RLM, whatever the NDP used.
The experimental conditions used to assay the NDPK re-
action merit a speci¢c discussion. In fact, since NDPK reac-
tion, ADP/ATP transport via the carrier and ATP synthesis
via ATP synthase are involved in the observed process, it is
necessary to verify that SRR actually re£ects NDPK activity.
This was made by applying the control strength criterion [8]
to the Dixon plots reported in Fig. 2. Our results demon-
strated that up to concentrations of 150 WM NDP, SRR
was a measure of NDPK reaction. It should be noted that
this was not previously considered [6].
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Fig. 3. A Dixon plot of the inhibition by AZT of the rate of NDPK reaction. RLM (2 mg protein) were incubated under the conditions de-
scribed in the legend to Fig. 1. TDP (A), UDP (B), CDP (C) or GDP (D) was added to RLM in the absence or in the presence of increasing
concentrations of AZT. The insets of each panel report the plots of 1/i against 1/AZT: where l = 13SRRi/SRRo, SRRi and SRRo being the
rates measured in the presence and absence of the inhibitor, respectively.
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The kinetic analysis of the nature of the inhibition by AZT
gives some insight into the AZT-NDPK interaction. We show
that AZT is a competitive inhibitor of NDPK, with a Ki of
about 10 WM, as measured for each NDP used as a substrate.
In the light of both the Ki value and the NDP Km values
measured here and, moreover, in the light of the reported
AZT accumulation in the intermembrane space [4], we assume
that such an inhibition could occur also in vivo. Taking in
consideration the physiological role of the mitochondrial
NDPK in the NTP production, coupled to oxidative phos-
phorylation, and in their channelling in various anabolic proc-
esses [5], the in vivo AZT inhibition might reduce the cellular
availability of the NTP.
Interestingly, the nature of AZT inhibition on NDPK was
found to change with the concentration of the NDP used as
substrates of NDPK. In fact, up to 75^100 WM NDP, the
AZT inhibition of NDPK was pure competitive, making it
likely that AZT competes with NDP for the same binding
site. In the presence of 150 WM NDP, AZT behaves as a
partial competitive inhibitor, thus showing that AZT can
bind to another saturable site. Among the tested nucleotides,
high concentrations of GDP were found to prevent the AZT
inhibition. Such a prevention is consistent with the binding of
GDP as a NDPK inhibitor, perhaps to the enzyme site re-
sponsible for the partial competitive inhibition by AZT. Thus,
we suggest that in the presence of high NDP/NTP concentra-
tions, the NDPK conformation changes, thus allowing GDP
regulation in vivo and perhaps AZT inhibition. Although the
mechanism of GDP-AZT NDPK inhibition remains to be
elucidated, the usefulness of GDP in ATP de¢ciency syn-
drome prevention merits further research.
The impairment of the mitochondrial NDPK together with
the inhibition of adenylate kinase [3] and the ADP/ATP car-
rier [4], could be the biochemical process that causes an early
damage to the energy metabolism, responsible for the ATP
de¢ciency syndrome induced in cells treated with AZT [2].
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Fig. 4. The dependence of NDPK reaction rate on GDP concentration: e¡ect of AZT. RLM (2 mg protein) were incubated under the condi-
tions described in the legend to Fig. 1. Increasing concentrations of GDP were added in the absence or in the presence of AZT (15 WM). The
inset reports the plot of 1/SRR against 1/GDP as measured either in the absence (E) or in the presence (U) of AZT.
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